Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 658913, 14 pages
http://dx.doi.org/10.1155/2014/658913
Review Article

New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases

1CEINGE-Biotecnologie Avanzate Scarl, Via Salvatore 486, 80145 Napoli, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via De Amicis 95, 80131 Napoli, Italy
3Dipartimento di Scienze Cardio-Toraciche e Respiratorie, Seconda Università degli Studi di Napoli, Via Bianchi 1, 80131 Napoli, Italy
4Cattedra di Malattie dell’Apparato Visivo, Dipartimento di Medicina e Scienze della Salute, Università del Molise, Via De Sanctis 1, 86100 Campobasso, Italy
5Cattedra di Malattie dell’Apparato Respiratorio, Dipartimento di Medicina e Scienze della Salute, Università del Molise, Via De Sanctis 1, 86100 Campobasso, Italy
6Dipartimento di Scienze e Tecnologie Ambientali Biologiche Farmaceutiche, Seconda Università degli Studi di Napoli, Via Vivaldi 42, 81100 Caserta, Italy

Received 2 April 2014; Accepted 12 June 2014; Published 7 July 2014

Academic Editor: Beverly Muhlhausler

Copyright © 2014 Ersilia Nigro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Wright and L. J. Aronne, “Causes of obesity,” Abdominal Imaging, vol. 37, no. 5, pp. 730–732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Friedman, “Obesity in the new millennium,” Nature, vol. 404, no. 6778, pp. 632–634, 2000. View at Google Scholar · View at Scopus
  3. K. R. Fitzgerald, “Review of article: prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 by Katherine M. Flegal, PhD; Margaret D. Carroll, MSPH; Brian K. Kit, MD; Cynthia L. Ogden, PhD (JAMA 2012;307:491-7),” Journal of Vascular Nursing, vol. 31, no. 3, pp. 131–132, 2013. View at Publisher · View at Google Scholar
  4. T. H. I. Fakhouri, C. L. Ogden, M. D. Carroll, B. K. Kit, and K. M. Flegal, “Prevalence of obesity among older adults in the United States, 2007–2010.,” National Center for Health Statistics Data Brief, no. 106, pp. 1–8, 2012. View at Google Scholar · View at Scopus
  5. A. Berghöfer, T. Pischon, T. Reinhold, C. M. Apovian, A. M. Sharma, and S. N. Willich, “Obesity prevalence from a European perspective: a systematic review,” BMC Public Health, vol. 8, article 200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. N. Hales and D. J. P. Barker, “The thrifty phenotype hypothesis,” British Medical Bulletin, vol. 60, pp. 5–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Srivastava, R. Lakhan, and B. Mittal, “Pathophysiology and genetics of obesity,” Indian Journal of Experimental Biology, vol. 45, no. 11, pp. 929–936, 2007. View at Google Scholar · View at Scopus
  8. Q. Xia and S. F. A. Grant, “The genetics of human obesity,” Annals of the New York Academy of Sciences, vol. 1281, no. 1, pp. 178–190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Alfieri, F. Pasanisi, S. Salzano et al., “Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy,” Gene, vol. 457, no. 1-2, pp. 35–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Kakar, J. Ahmad, C. Kubisch, and G. Borck, “Exon skipping and severe childhood-onset obesity caused by a leptin receptor mutation,” American Journal of Medical Genetics A, vol. 161, no. 10, pp. 2672–2674, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. I. S. Farooqi, S. Drop, A. Clements et al., “Heterozygosity for a POMC-null mutation and increased obesity risk in humans,” Diabetes, vol. 55, no. 9, pp. 2549–2553, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Argyropoulos, T. Rankinen, D. R. Neufeld et al., “A polymorphism in the human agouti-related protein is associated with late-onset obesity,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 9, pp. 4198–4202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. I. S. Goldlust, K. E. Hermetz, L. M. Catalano et al., “Mouse model implicates GNB3 duplication in a childhood obesity syndrome,” Proceedings of the National Academy of Sciences, vol. 110, no. 37, pp. 14990–14994, 2013. View at Publisher · View at Google Scholar
  14. C. J. Willer, E. K. Speliotes, and R. J. Loos, “Six new loci associated with body mass index highlight a neuronal influence on body weight regulation,” Nature Genetics, vol. 41, no. 1, pp. 25–34, 2009. View at Publisher · View at Google Scholar
  15. J. Cao, N. Puri, K. Sodhi, L. Bellner, N. G. Abraham, and A. Kappas, “Apo A1 mimetic rescues the diabetic phenotype of HO-2 knockout mice via an increase in HO-1 adiponectin and LKBI signaling pathway,” International Journal of Hypertension, vol. 2012, Article ID 628147, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. E. K. Speliotes, C. J. Willer, and S. I. Berndt, “Association analyses of 249, 796 individuals reveal eighteen new loci associated with body mass index,” Nature Genetics, vol. 42, no. 11, pp. 937–948, 2010. View at Google Scholar
  17. G. Thorleifsson, G. B. Walters, D. F. Gudbjartsson et al., “Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity,” Nature Genetics, vol. 41, no. 1, pp. 18–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Mohamed-Ali, J. H. Pinkney, and S. W. Coppack, “Adipose tissue as an endocrine and paracrine organ,” International Journal of Obesity, vol. 22, no. 12, pp. 1145–1158, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Rega-Kaun, C. Kaun, and J. Wojta, “More than a simple storage organ: adipose tissue as a source of adipokines involved in cardiovascular disease,” Thrombosis and Haemostasis, vol. 110, no. 4, pp. 641–50, 2013. View at Publisher · View at Google Scholar
  20. H. Kwon and J. E. Pessin, “Adipokines mediate inflammation and insulin resistance,” Frontiers in Endocrinology, vol. 4, article 71, 2013. View at Publisher · View at Google Scholar
  21. P. E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish, “A novel serum protein similar to C1q, produced exclusively in adipocytes,” The Journal of Biological Chemistry, vol. 270, no. 45, pp. 26746–26749, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara, “cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1),” Biochemical and Biophysical Research Communications, vol. 221, no. 2, pp. 286–289, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Nakano, T. Tobe, N. Choi-Miura, T. Mazda, and M. Tomita, “Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma,” Journal of Biochemistry, vol. 120, no. 4, pp. 803–812, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. P. A. Kern, G. B. di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan, “Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression,” Diabetes, vol. 52, no. 7, pp. 1779–1785, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Lee and J. Shao, “Adiponectin and energy homeostasis,” Reviews in Endocrine and Metabolic Disorders, vol. 15, no. 2, pp. 149–156, 2014. View at Publisher · View at Google Scholar
  27. K. Ohashi, N. Ouchi, and Y. Matsuzawa, “Anti-inflammatory and anti-atherogenic properties of adiponectin,” Biochimie, vol. 94, no. 10, pp. 2137–2142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Daniele, R. Cammarata, M. Masullo et al., “Analysis of adiponectin gene and comparison of its expression in two different pig breeds,” Obesity, vol. 16, no. 8, pp. 1869–1874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. de Rosa, M. Ludovica Monaco, M. Capasso et al., “Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects,” European Journal of Endocrinology, vol. 169, no. 1, pp. 37–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Schraw, Z. V. Wang, N. Halberg, M. Hawkins, and P. E. Scherer, “Plasma adiponectin complexes have distinct biochemical characteristics,” Endocrinology, vol. 149, no. 5, pp. 2270–2282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Fruebis, T. S. Tsao, S. Javorschi et al., “Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 4, pp. 2005–2010, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Kishida, H. Nagaretani, H. Kondo et al., “Disturbed secretion of mutant adiponectin associated with the metabolic syndrome,” Biochemical and Biophysical Research Communications, vol. 306, no. 1, pp. 286–292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Ge, Y. Xiong, B. Lemon et al., “Generation of novel long-acting globular adiponectin molecules,” Journal of Molecular Biology, vol. 399, no. 1, pp. 113–119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Waki, T. Yamauchi, J. Kamon et al., “Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1,” Endocrinology, vol. 146, no. 2, pp. 790–796, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Almer, M. Saba-Lepek, S. Haj-Yahya et al., “Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions,” Biologics, vol. 5, pp. 95–105, 2011. View at Publisher · View at Google Scholar
  36. J. P. Wen, C. E. Liu, Y. T. Hu, G. Chen, and L. X. Lin, “Globular adiponectin regulates energy homeostasis through AMP-activated protein kinase-acetyl-CoA carboxylase (AMPK/ACC) pathway in the hypothalamus,” Molecular and Cellular Biochemistry, vol. 344, no. 1-2, pp. 109–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. U. B. Pajvani, X. Du, T. P. Combs et al., “Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: Implications for metabolic regulation and bioactivity,” The Journal of Biological Chemistry, vol. 278, no. 11, pp. 9073–9085, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Simpson and J. P. Whitehead, “Adiponectin—it’s all about the modifications,” The International Journal of Biochemistry & Cell Biology, vol. 42, no. 6, pp. 785–788, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. E. K. Calton, V. S. Miller, and M. J. Soares, “Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?” The European Journal of Clinical Nutrition, vol. 67, no. 5, pp. 485–491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Daniele, A. de Rosa, M. de Cristofaro et al., “Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1,” European Journal of Endocrinology, vol. 165, no. 6, pp. 969–975, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Daniele, A. De Rosa, E. Nigro et al., “Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease,” The International Journal of Biochemistry and Cell Biology, vol. 44, no. 3, pp. 563–569, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Liu and F. Liu, “Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication,” Biochimie, vol. 94, no. 10, pp. 2126–2130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Vasseur, N. Helbecque, C. Dina et al., “Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians,” Human Molecular Genetics, vol. 11, no. 21, pp. 2607–2614, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Hara, P. Boutin, Y. Mori et al., “Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population,” Diabetes, vol. 51, no. 2, pp. 536–540, 2002. View at Google Scholar · View at Scopus
  45. H. Waki, T. Yamauchi, J. Kamon et al., “Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin,” The Journal of Biological Chemistry, vol. 278, no. 41, pp. 40352–40363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Kondo, I. Shimomura, Y. Matsukawa et al., “Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome,” Diabetes, vol. 51, no. 7, pp. 2325–2328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Daniele, R. Cammarata, F. Pasanisi et al., “Molecular analysis of the adiponectin gene in severely obese patients from Southern Italy,” Annals of Nutrition and Metabolism, vol. 53, no. 3-4, pp. 155–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Bracale, G. Labruna, C. Finelli et al., “The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance,” Journal of Endocrinological Investigation, vol. 35, no. 1, pp. 2–4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. V. J. Bermúdez, E. Rojas, A. Toledo et al., “Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: Insulin resistance and type 2 diabetes mellitus candidate genes,” American Journal of Therapeutics, vol. 20, no. 4, pp. 414–421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Hug, J. Wang, N. S. Ahmad, J. S. Bogan, T. S. Tsao, and H. F. Lodish, “T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 28, pp. 10308–10313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Yamauchi, Y. Nio, T. Maki et al., “Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions,” Nature Medicine, vol. 13, no. 3, pp. 332–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Ye and P. E. Scherer, “Adiponectin, driver or passenger on the road to insulin sensitivity?” Molecular Metabolism, vol. 2, no. 3, pp. 133–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Wu, H. Motoshima, K. Mahadev, T. J. Stalker, R. Scalia, and B. J. Goldstein, “Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes,” Diabetes, vol. 52, no. 6, pp. 1355–1363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. J. R. Rao, D. J. Keating, C. Chen, and H. C. Parkington, “Adiponectin increases insulin content and cell proliferation in MIN6 cells via PPARγ-dependent and PPARγ-independent mechanisms,” Diabetes, Obesity and Metabolism, vol. 14, no. 11, pp. 983–989, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. N. Wijesekara, M. Krishnamurthy, A. Bhattacharjee, A. Suhail, G. Sweeney, and M. B. Wheeler, “Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion,” The Journal of Biological Chemistry, vol. 285, no. 44, pp. 33623–33631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Wedellová, J. Dietrich, M. Šiklová-Vítková et al., “Adiponectin inhibits spontaneous and catecholamine-induced lipolysis in human adipocytes of non-obese subjects through AMPK-dependent mechanisms,” Physiological Research, vol. 60, no. 1, pp. 139–148, 2011. View at Google Scholar · View at Scopus
  57. M. T. Villarreal-Molina and B. Antuna-Puente, “Adiponectin: anti-inflammatory and cardioprotective effects,” Biochimie, vol. 94, no. 10, pp. 2143–2149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Ouchi and K. Walsh, “Adiponectin as an anti-inflammatory factor,” Clinica Chimica Acta, vol. 380, no. 1-2, pp. 24–30, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Subedi and P. H. Park, “Autocrine and paracrine modulation of microRNA-155 expression by globular adiponectin in RAW 264.7 macrophages: involvement of MAPK/NF-κB pathway,” Cytokine, vol. 64, no. 3, pp. 638–641, 2013. View at Google Scholar
  60. E. Nigro, O. Scudiero, D. Sarnataro et al., “Adiponectin affects lung epithelial A549 cell viability counteracting TNFa and IL-1ß toxicity through AdipoR1,” International Journal of Biochemistry and Cell Biology, vol. 45, no. 6, pp. 1145–1153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Ouchi, M. Ohishi, S. Kihara et al., “Association of hypoadiponectinemia with impaired vasoreactivity,” Hypertension, vol. 42, no. 3, pp. 231–234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Shibata, N. Ouchi, S. Kihara, K. Sato, T. Funahashi, and K. Walsh, “Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling,” Journal of Biological Chemistry, vol. 279, no. 27, pp. 28670–28674, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Kobayashi, N. Ouchi, S. Kihara et al., “Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin.,” Circulation research, vol. 94, no. 4, pp. e27–31, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Dalamaga, K. N. Diakopoulos, and C. S. Mantzoros, “The role of adiponectin in cancer: a review of current evidence,” Endocrine Reviews, vol. 33, no. 4, pp. 547–594, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Obeid and L. Hebbard, “Role of adiponectin and its receptors in cancer,” Cancer Biology and Medicine, vol. 9, no. 4, pp. 213–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Lang and J. Ratke, “Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration,” Cell Communication and Signaling, vol. 7, article 27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. P. Scheid and G. Sweeney, “The role of adiponectin signaling in metabolic syndrome and cancer,” Reviews in Endocrine and Metabolic Disorders, vol. 15, no. 2, pp. 157–167, 2013. View at Google Scholar
  68. A. Y. Kim, Y. S. Lee, K. H. Kim et al., “Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation,” Molecular Endocrinology, vol. 24, no. 7, pp. 1441–1452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. M. R. Nalabolu, K. Palasamudram, and K. Jamil, “Adiponectin and leptin molecular actions and clinical significance in breast cancer,” International Journal of Hematology-Oncology and Stem Cell Research, vol. 8, no. 1, pp. 31–40, 2014. View at Google Scholar
  70. O. O. Ogunwobi and I. L. P. Beales, “Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells,” Regulatory Peptides, vol. 134, no. 2-3, pp. 105–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. M. H. Lee, R. L. Klein, H. M. El-Shewy, D. K. Luttrell, and L. M. Luttrell, “The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth,” Biochemistry, vol. 47, no. 44, pp. 11682–11692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Kaser, T. Tatarczyk, A. Stadlmayr et al., “Effect of obesity and insulin sensitivity on adiponectin isoform distribution,” European Journal of Clinical Investigation, vol. 38, no. 11, pp. 827–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. L. K. Meyer, T. P. Ciaraldi, R. R. Henry, A. C. Wittgrove, and S. A. Phillips, “Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity,” Adipocyte, vol. 2, no. 4, pp. 217–226, 2013. View at Publisher · View at Google Scholar
  74. M. P. Hamilton, M. O. Gore, C. R. Ayers, X. Wu, D. K. McGuire, and P. E. Scherer, “Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: Parameters associated with adiponectin complex distribution,” Diabetes and Vascular Disease Research, vol. 8, no. 3, pp. 190–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Drolet, C. Bélanger, M. Fortier et al., “Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women,” Obesity, vol. 17, no. 3, pp. 424–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Ramya, K. A. Ayyappa, S. Ghosh, V. Mohan, and V. Radha, “Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population,” Gene, vol. 532, no. 2, pp. 253–262, 2013. View at Publisher · View at Google Scholar
  77. T. I. Pollin, K. Tanner, J. R. O'Connell et al., “Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene,” Diabetes, vol. 54, no. 1, pp. 268–274, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Stumvoll, O. Tschritter, A. Fritsche et al., “Association of the T-G polymorphism in adiponectin (Exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes,” Diabetes, vol. 51, no. 1, pp. 37–41, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. J. G. Woo, L. M. Dolan, R. Deka et al., “Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin,” Diabetes, vol. 55, no. 2, pp. 523–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. G. de Pergola and F. Silvestris, “Obesity as a major risk factor for cancer,” Journal of Obesity, vol. 2013, Article ID 291546, 11 pages, 2013. View at Publisher · View at Google Scholar
  81. A. Avogaro and S. V. de Kreutzenberg, “Mechanisms of endothelial dysfunction in obesity,” Clinica Chimica Acta, vol. 360, no. 1-2, pp. 9–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. C. M. Diaz-Melean, V. K. Somers, and J. P. Rodriguez-Escudero, “Mechanisms of adverse cardiometabolic consequences of obesity,” Current Atherosclerosis Reports, vol. 15, no. 11, p. 364, 2013. View at Google Scholar
  83. M. Matsuda and I. Shimomura, “Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases,” Reviews in Endocrine and Metabolic Disorders, vol. 15, no. 1, pp. 1–10, 2014. View at Google Scholar
  84. M. Cnop, P. J. Havel, K. M. Utzschneider et al., “Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex,” Diabetologia, vol. 46, no. 4, pp. 459–469, 2003. View at Google Scholar · View at Scopus
  85. N. H. Kim, N. H. Cho, C. H. Yun et al., “Association of obstructive sleep apnea and glucose metabolism in subjects with or without obesity,” Diabetes Care, vol. 36, no. 12, pp. 3909–3915, 2013. View at Publisher · View at Google Scholar
  86. A. M. Wolf, D. Wolf, H. Rumpold, B. Enrich, and H. Tilg, “Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes,” Biochemical and Biophysical Research Communications, vol. 323, no. 2, pp. 630–635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. H. Demirci, C. Nuhoglu, I. S. Ursavas, S. Isildak, E. O. Basaran, and M. Y. Kilic, “Obesity and asymptomatic hypertension among children aged 6–13 years living in Bursa, Turkey,” Family Practice, vol. 30, no. 6, pp. 629–633, 2013. View at Google Scholar
  88. N. Ouchi, S. Kihara, T. Funahashi, Y. Matsuzawa, and K. Walsh, “Obesity, adiponectin and vascular inflammatory disease,” Current Opinion in Lipidology, vol. 14, no. 6, pp. 561–566, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. Iwashima, T. Katsuya, K. Ishikawa et al., “Hypoadiponectinemia is an independent risk factor for hypertension,” Hypertension, vol. 43, no. 6, pp. 1318–1323, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Di Chiara, A. Licata, C. Argano, G. Duro, S. Corrao, and R. Scaglione, “Plasma adiponectin: a contributing factor for cardiac changes in visceral obesity-associated hypertension,” Blood Pressure, vol. 23, no. 3, pp. 147–153, 2014. View at Publisher · View at Google Scholar
  91. N. Ouchi, S. Kihara, Y. Arita et al., “Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages,” Circulation, vol. 103, no. 8, pp. 1057–1063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. Z. Chen, I. Peng, W. Sun et al., “AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase ser633,” Circulation Research, vol. 104, no. 4, pp. 496–505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. A. V. Mathew, S. Okada, and K. Sharma, “Obesity related kidney disease,” Current Diabetes Reviews, vol. 7, no. 1, pp. 41–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Tesauro, A. Mascali, O. Franzese, S. Cipriani, C. Cardillo, and N. di Daniele, “Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin,” International Journal of Hypertension, vol. 2012, Article ID 943605, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. V. Menon, L. Li, X. Wang et al., “Adiponectin and mortality in patients with chronic kidney disease,” Journal of the American Society of Nephrology, vol. 17, no. 9, pp. 2599–2606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. S. A. Bakkaloglu, O. Soylemezoglu, N. Buyan et al., “High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse,” Pediatric Nephrology, vol. 20, no. 4, pp. 474–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. N. Komura, S. Kihara, M. Sonoda et al., “Increment and impairment of adiponectin in renal failure,” Cardiovascular Research, vol. 86, no. 3, pp. 471–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. K. Sharma, S. RamachandraRao, G. Qiu et al., “Adiponectin regulates albuminuria and podocyte function in mice,” The Journal of Clinical Investigation, vol. 118, no. 5, pp. 1645–1656, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. Y. Shimamoto, M. Mizukoshi, A. Kuroi et al., “Is visceral fat really a coronary risk factor?” International Heart Journal, vol. 54, no. 5, pp. 273–278, 2013. View at Google Scholar
  100. S. H. Choi, E. S. Hong, and S. Lim, “Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health,” Frontiers in Endocrinology, vol. 4, article 97, 2013. View at Publisher · View at Google Scholar
  101. N. Sattar, P. Watt, L. Cherry, S. Ebrahim, G. D. Smith, and D. A. Lawlor, “High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1846–1849, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Matsuda, I. Shimomura, M. Sata et al., “Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis,” Journal of Biological Chemistry, vol. 277, no. 40, pp. 37487–37491, 2002. View at Publisher · View at Google Scholar · View at Scopus
  103. N. Ouchi and K. Walsh, “Cardiovascular and metabolic regulation by the adiponectin/C1q/tumor necrosis factor-related protein family of proteins,” Circulation, vol. 125, no. 25, pp. 3066–3068, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. G. Mazzarella, V. Esposito, A. Bianco et al., “Inflammatory effects on human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM1.0) and pollen allergens,” Environmental Pollution, vol. 161, pp. 64–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. V. Esposito, A. Lucariello, L. Savarese et al., “Morphology changes in human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM1.0) and pollen allergens,” Environmental Pollution, vol. 171, pp. 162–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. G. Mazzarella, F. Ferraraccio, M. V. Prati et al., “Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study,” Respiratory Medicine, vol. 101, no. 6, pp. 1155–1162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. E. Grella, G. Paciocco, U. Caterino, and G. Mazzarella, “Respiratory function and atmospheric pollution,” Monaldi Archives for Chest Disease, vol. 57, no. 3-4, pp. 196–199, 2002. View at Google Scholar · View at Scopus
  108. G. de Laurentiis, D. Paris, D. Melck et al., “Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate,” Journal of Proteome Research, vol. 12, no. 3, pp. 1502–1511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. G. Corbi, A. Bianco, V. Turchiarelli et al., “Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on sirtuins,” International Journal of Molecular Sciences, vol. 14, no. 6, pp. 12696–12713, 2013. View at Publisher · View at Google Scholar · View at Scopus
  110. L. M. Cecere, A. J. Littman, C. G. Slatore et al., “Obesity and COPD: associated symptoms, health-related quality of life, and medication use,” Journal of Chronic Obstructive Pulmonary Disease, vol. 8, no. 4, pp. 275–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. F. M. E. Franssen, D. E. O'Donnell, G. H. Goossens, E. E. Blaak, and A. M. W. J. Schols, “Obesity and the lung: 5 · Obesity and COPD,” Thorax, vol. 63, no. 12, pp. 1110–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Bianco, G. Mazzarella, V. Turchiarelli et al., “Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD),” Nutrients, vol. 5, no. 10, pp. 4115–4125, 2013. View at Google Scholar
  113. K. H. Chan, S. C. Yeung, T. J. Yao et al., “Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease,” International Journal of Tuberculosis and Lung Disease, vol. 14, no. 9, pp. 1193–1200, 2010. View at Google Scholar · View at Scopus
  114. H. Liu, J. S. Liu, J. Huang, L. W. Zhong, and J. Y. Xu, “Unique association of adiponectin isoforms with serum cytokines and redox molecules in patients with chronic obstructive pulmonary disease,” Chinese Medical Journal (English Edition), vol. 126, no. 17, pp. 3383–3384, 2013. View at Google Scholar
  115. R. Summer, C. A. Fiack, Y. Ikeda et al., “Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 297, no. 3, pp. L432–L438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. J. L. Mathew and I. Narang, “Sleeping too close together: obesity and obstructive sleep apnea in childhood and adolescence,” Paediatric Respiratory Reviews, 2013. View at Publisher · View at Google Scholar
  117. T. A. Hargens, S. G. Guill, A. S. Kaleth et al., “Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea,” Sleep and Breathing, vol. 17, no. 1, pp. 403–409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. Nakagawa, K. Kishida, S. Kihara, R. Yoshida, T. Funahashi, and I. Shimomura, “Nocturnal falls of adiponectin levels in sleep apnea with abdominal obesity and impact of hypoxia-induced dysregulated adiponectin production in obese murine mesenteric adipose tissue,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 3, pp. 240–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. U. J. Magalang, J. P. Cruff, R. Rajappan et al., “Intermittent hypoxia suppresses adiponectin secretion by adipocytes,” Experimental and Clinical Endocrinology and Diabetes, vol. 117, no. 3, pp. 129–134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. B. E. K. Klein, “Overview of epidemiologic studies of diabetic retinopathy,” Ophthalmic Epidemiology, vol. 14, no. 4, pp. 179–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. M. I. Yilmaz, A. Sonmez, C. Acikel et al., “Adiponectin may play a part in the pathogenesis of diabetic retinopathy,” European Journal of Endocrinology, vol. 151, no. 1, pp. 135–140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. H. Misu, K. Ishikura, S. Kurita et al., “Inverse correlation between serum levels of selenoprotein p and adiponectin in patients with type 2 diabetes,” PLoS ONE, vol. 7, no. 4, Article ID e34952, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. C. Costagliola, A. Daniele, R. dell'Omo et al., “Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection,” Experimental Eye Research, vol. 110, pp. 50–54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. D. Mao, H. Peng, Q. Li et al., “Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients,” Current Eye Research, vol. 37, no. 9, pp. 803–808, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Cunha-Vaz, J. R. F. De Abreu, A. J. Campos, and G. M. Figo, “Early breakdown of the blood retinal barrier in diabetes,” British Journal of Ophthalmology, vol. 59, no. 11, pp. 649–656, 1975. View at Publisher · View at Google Scholar · View at Scopus
  126. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M. J. Quon, “Adiponectin stimulates production of nitric oxide in vascular endothelial cells,” Journal of Biological Chemistry, vol. 278, no. 45, pp. 45021–45026, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. D. Fukumura, A. Ushiyama, D. G. Duda et al., “Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis.,” Circulation Research, vol. 93, no. 9, pp. e88–e97, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. K. Iskander, R. Farhour, M. Ficek, and A. Ray, “Obesity-related complications: Few biochemical phenomena with reference to tumorigenesis,” Malaysian Journal of Pathology, vol. 35, no. 1, pp. 1–15, 2013. View at Google Scholar · View at Scopus
  129. M. L. Kwan, E. M. John, B. J. Caan et al., “Obesity and mortality after Breast Cancer by Race/Ethnicity: the California Breast Cancer Survivorship Consortium,” American Journal of Epidemiology, vol. 179, no. 1, pp. 95–111, 2013. View at Google Scholar
  130. E. Surmacz and J. Mammary, “Leptin and adiponectin: emerging therapeutic targets in breast cancer,” Journal of Mammar Gland Biology and Neoplasia, vol. 18, no. 3-4, pp. 321–332, 2013. View at Publisher · View at Google Scholar
  131. Y. Ohbuchi, Y. Suzuki, I. Hatakeyama et al., “A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer,” International Journal of Clinical Oncology, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. T. Kerenidi, M. Lada, A. Tsaroucha, P. Georgoulias, P. Mystridou, and K. I. Gourgoulianis, “Clinical significance of serum adipokines levels in lung cancer,” Medical Oncology, vol. 30, no. 2, article 507, 2013. View at Publisher · View at Google Scholar · View at Scopus
  133. F. Kosova, T. Coskun, Y. Kaya, E. Kara, and Z. Ari, “Adipocytokine levels of colon cancer patients before and after treatment,” Bratislava Medical Journal, vol. 114, no. 7, pp. 394–397, 2013. View at Publisher · View at Google Scholar · View at Scopus
  134. L. M. Liao, K. Schwartz, M. Pollak et al., “Serum leptin and adiponectin levels and risk of renal cell carcinoma,” Obesity, vol. 21, no. 7, pp. 1478–1485, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. E. T. Petridou, N. Mitsiades, S. Gialamas et al., “Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies,” Oncology, vol. 73, no. 3-4, pp. 261–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. M. E. Grossmann, K. J. Nkhata, N. K. Mizuno, A. Ray, and M. P. Cleary, “Effects of adiponectin on breast cancer cell growth and signaling,” British Journal of Cancer, vol. 98, no. 2, pp. 370–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  137. S. Nakayama, Y. Miyoshi, H. Ishihara, and S. Noguchi, “Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis,” Breast Cancer Research and Treatment, vol. 112, no. 3, pp. 405–410, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. A. P. Courcoulas, N. J. Christian, S. H. Belle et al., “Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity,” The Journal of the American Medical Association, vol. 310, no. 22, pp. 2416–2425, 2013. View at Google Scholar
  139. S. F. Noria and T. Grantcharov, “Biological effects of bariatric surgery on obesity-related comorbidities,” Canadian Journal of Surgery, vol. 56, no. 1, pp. 47–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. J. Salas-Salvadó, M. Bulló, P. García-Lorda et al., “Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss,” International Journal of Obesity, vol. 30, no. 12, pp. 1714–1720, 2006. View at Publisher · View at Google Scholar · View at Scopus
  141. E. P. Weiss, S. B. Racette, D. T. Villareal et al., “Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial,” The American Journal of Clinical Nutrition, vol. 84, no. 5, pp. 1033–1042, 2006. View at Google Scholar · View at Scopus
  142. K. A. Simpson and M. A. F. Singh, “Effects of exercise on adiponectin: a systematic review,” Obesity, vol. 16, no. 2, pp. 241–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  143. M. H. Rokling-Andersen, J. E. Reseland, M. B. Veierød et al., “Effects of long-term exercise and diet intervention on plasma adipokine concentrations,” The American Journal of Clinical Nutrition, vol. 86, no. 5, pp. 1293–1301, 2007. View at Google Scholar · View at Scopus
  144. T. Christiansen, S. K. Paulsen, J. M. Bruun, T. Ploug, S. B. Pedersen, and B. Richelsen, “Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 2, pp. 911–919, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. Y. Yamazaki, Y. Kawano, and M. Uebayasi, “Induction of adiponectin by natural and synthetic phenolamides in mouse and human preadipocytes and its enhancement by docosahexaenoic acid,” Life Sciences, vol. 82, no. 5-6, pp. 290–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. T. Tsuda, Y. Ueno, H. Aoki et al., “Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes,” Biochemical and Biophysical Research Communications, vol. 316, no. 1, pp. 149–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  147. H. Nozawa, “Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-Ay mice,” Biochemical and Biophysical Research Communications, vol. 336, no. 3, pp. 754–761, 2005. View at Publisher · View at Google Scholar · View at Scopus
  148. A. Moriuchi, H. Yamasaki, M. Shimamura et al., “Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-γ activation,” Biochemical and Biophysical Research Communications, vol. 356, no. 4, pp. 1024–1030, 2007. View at Publisher · View at Google Scholar · View at Scopus
  149. A. Hiuge, A. Tenenbaum, N. Maeda et al., “Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 3, pp. 635–641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. J. M. Bruun, A. Roeske-Nielsen, B. Richelsen, P. Fredman, and K. Buschard, “Sulfatide increases adiponectin and decreases TNF-α, IL-6, and IL-8 in human adipose tissue in vitro,” Molecular and Cellular Endocrinology, vol. 263, no. 1-2, pp. 142–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. N. Adamia, D. Virsaladze, N. Charkviani, M. Skhirtladze, and M. Khutsishvili, “Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes,” Georgian Medical News, no. 145, pp. 52–55, 2007. View at Google Scholar · View at Scopus
  152. A. Sahebkar, “Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: a systematic review and meta-analysis,” Metabolism, vol. 62, no. 12, pp. 1876–1885, 2013. View at Google Scholar
  153. A. Tsuchida, T. Yamauchi, S. Takekawa et al., “Peroxisome proliferator-activated receptor (PPAR)α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARα, PPARγ, and their combination,” Diabetes, vol. 54, no. 12, pp. 3358–3370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  154. S. A. Phillips, T. P. Ciaraldi, D. K. Oh, M. K. Savu, and R. R. Henry, “Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue,” The American Journal of Physiology: Endocrinology and Metabolism, vol. 295, no. 4, pp. E842–E850, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. M. Liu and F. Liu, “Transcriptional and post-translational regulation of adiponectin,” Biochemical Journal, vol. 425, no. 1, pp. 41–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. Y. Liu, S. Turdi, T. Park et al., “Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis,” Diabetes, vol. 62, no. 3, pp. 743–752, 2013. View at Publisher · View at Google Scholar · View at Scopus
  157. K. Kondo, R. Shibata, K. Unno et al., “Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model,” Circulation: Cardiovascular Interventions, vol. 3, no. 2, pp. 166–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. T. Yamauchi, J. Kamon, H. Waki et al., “Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis,” Journal of Biological Chemistry, vol. 278, no. 4, pp. 2461–2468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  159. L. Otvos, E. Haspinger, F. LaRussa et al., “Design and development of a peptide-based adiponectin receptor agonist for cancer treatment,” BMC Biotechnology, vol. 11, article 90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  160. Y. Sun, Z. Zang, L. Zhong et al., “Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay,” PLoS ONE, vol. 8, no. 5, Article ID e63354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  161. M. Okada-Iwabu, T. Yamauchi, M. Iwabu et al., “A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity,” Nature, vol. 503, no. 7477, pp. 493–499, 2013. View at Google Scholar
  162. S. E. Kasim-Karakas, A. Tsodikov, U. Singh, and I. Jialal, “Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake,” The American Journal of Clinical Nutrition, vol. 83, no. 4, pp. 774–779, 2006. View at Google Scholar · View at Scopus
  163. K. He, F. B. Hu, G. A. Colditz, J. E. Manson, W. C. Willett, and S. Liu, “Changes in intake of fruits and vegetables in relation to risk of obesity and weight gain among middle-aged women,” International Journal of Obesity, vol. 28, no. 12, pp. 1569–1574, 2004. View at Publisher · View at Google Scholar · View at Scopus
  164. T. L. Nelson, J. R. Stevens, and M. S. Hickey, “Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with α-linolenic acid among healthy adults,” Metabolism: Clinical and Experimental, vol. 56, no. 9, pp. 1209–1215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  165. M. A. Micallef and M. L. Garg, “Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals,” Atherosclerosis, vol. 204, no. 2, pp. 476–482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  166. G. Grunberger, K. L. Jen, and J. D. Artiss, “The benefits of early intervention in obese diabetic patients with FBCx: a new dietary fibre,” Diabetes/Metabolism Research and Reviews, vol. 23, no. 1, pp. 56–62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  167. M. W. Hulver, D. Zheng, C. J. Tanner et al., “Adiponectin is not altered with exercise training despite enhanced insulin action,” American Journal of Physiology: Endocrinology and Metabolism, vol. 283, no. 4, pp. E861–E865, 2002. View at Google Scholar · View at Scopus
  168. M. Blüher, J. W. Bullen Jr., J. H. Lee et al., “Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 6, pp. 2310–2316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  169. M. Zhu, J. Miura, L. X. Lu et al., “Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization,” Experimental Gerontology, vol. 39, no. 7, pp. 1049–1059, 2004. View at Publisher · View at Google Scholar · View at Scopus